Clinical Significance of Stress Hyperglycemic Ratio and Glycemic Gap in Ischemic Stroke Patients Treated with Intravenous Thrombolysis

References

• Tu W-J, Hua Y, Yan F., et al. Prevalence of stroke in China, 2013–2019: a population-based study. Lancet Regional Health. 2022;28:100550.
   Google Scholar
• Group. NIoNDaSr-PSS. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1587. doi:10.1056/NEJM199512143332401
   PubMed Web of Science ®Google Scholar
• Mazya M, Egido JA, Ford GA, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe implementation of treatments in stroke (sits) symptomatic intracerebral hemorrhage risk score. Stroke. 2012;43:1524–1531. doi:10.1161/STROKEAHA.111.644815
   PubMed Web of Science ®Google Scholar
• Ahmed N, Eriksson N, Ford GA, et al. Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the safe implementation of treatments in stroke international stroke thrombolysis register (sits-istr). Arch Neurol. 2010;67:1123–1130. doi:10.1001/archneurol.2010.210
   PubMedGoogle Scholar
• Nordt TK, Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fibrinolysis. Arterioscler Thromb. 1993;13:1822.
   PubMed Web of Science ®Google Scholar
• Bluhmki E, Chamorro Á, Dávalos A, et al. Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ecass iii): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009;8:1095–1102. doi:10.1016/S1474-4422(09)70264-9
   PubMed Web of Science ®Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2019;50:e344–e418. doi:10.1161/STR.0000000000000211
   PubMed Web of Science ®Google Scholar
• Berge E, Whiteley W, Audebert H, et al. European stroke organisation (eso) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021;6:I–LXII. doi:10.1177/2396987321989865
   PubMed Web of Science ®Google Scholar
• Johnston KC, Bruno A, Pauls Q, et al. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the shine randomized clinical trial. JAMA. 2019;322:326–335. doi:10.1001/jama.2019.9346
   PubMed Web of Science ®Google Scholar
• Torbey MT, Pauls Q, Gentile N, et al. Intensive versus standard treatment of hyperglycemia in acute ischemic stroke patient: a randomized clinical trial subgroups analysis. Stroke. 2022;53:1510–1515. doi:10.1161/STROKEAHA.120.033048
   Web of Science ®Google Scholar
• Nathan DM, Kuenen J, Borg R, et al. Translating the a1c assay into estimated average glucose values. Diabetes Care. 2008;31:1473–1478. doi:10.2337/dc08-0545
   PubMed Web of Science ®Google Scholar
• Su YW, Hsu CY, Guo YW, Chen HS. Usefulness of the plasma glucose concentration-to-hba1c ratio in predicting clinical outcomes during acute illness with extreme hyperglycaemia. Diabetes Metab. 2017;43:40–47. doi:10.1016/j.diabet.2016.07.036
   PubMed Web of Science ®Google Scholar
• Lyden PBT, Tilley B, Welch KM, et al. Improved reliability of the nih stroke scale using video training. NINDS TPA stroke study group. Stroke. 1994;25:2220–2226. doi:10.1161/01.STR.25.11.2220
   PubMed Web of Science ®Google Scholar
• Adams HP, Kappelle LJ, Biller J, Love BB, Gordon DL. Marsh EE Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35–41. doi:10.1161/01.STR.24.1.35
   PubMed Web of Science ®Google Scholar
• Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (sits-most): an observational study. Lancet. 2007;369(9558):275–282. doi:10.1016/S0140-6736(07)60149-4
   PubMed Web of Science ®Google Scholar
• McArthur K, Pei Z, Quinn T. Optimising outcome assessment to improve quality and efficiency of stroke trials. Expert Rev Pharmacoecon Outcomes Res. 2014;14:101–111. doi:10.1586/14737167.2014.870479
   PubMed Web of Science ®Google Scholar
• Huybrechts KF, Caro JJ, Xenakis JJ, Vemmos KN. The prognostic value of the modified Rankin scale score for long-term survival after first-ever stroke. Results from the Athens stroke registry. Cerebrovasc Dis. 2008;26:381–387. doi:10.1159/000151678
   PubMed Web of Science ®Google Scholar
• Capes SE, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–2432. doi:10.1161/hs1001.096194
   PubMed Web of Science ®Google Scholar
• Ngiam JN, Cheong CWS, Leow AST, et al. Stress hyperglycaemia is associated with poor functional outcomes in patients with acute ischaemic stroke after intravenous thrombolysis. QJM. 2022;115:7–11. doi:10.1093/qjmed/hcaa253
   Web of Science ®Google Scholar
• Masrur S, Cox M, Bhatt DL, et al. Association of acute and chronic hyperglycemia with acute ischemic stroke outcomes post-thrombolysis: findings from get with the guidelines-stroke. J Am Heart Assoc. 2015;4:e002193. doi:10.1161/JAHA.115.002193
   Web of Science ®Google Scholar
• Long MT, Krinsley JS. Treatment of hyperglycemia in patients with acute stroke. JAMA. 2019;322:2248. doi:10.1001/jama.2019.16339
   Web of Science ®Google Scholar
• Choi KH, Kim JH, Kang KW, et al. Hba1c (glycated hemoglobin) levels and clinical outcome post-mechanical thrombectomy in patients with large vessel occlusion. Stroke. 2018;50(1):119.
   Web of Science ®Google Scholar
• Jing J, Pan Y, Zhao X, et al. Prognosis of ischemic stroke with newly diagnosed diabetes mellitus according to hemoglobin a1c criteria in Chinese population. Stroke. 2016;47:2038–2044. doi:10.1161/STROKEAHA.116.013606
   Web of Science ®Google Scholar
• Wang A, Cui T, Wang C, et al. Prognostic significance of admission glucose combined with hemoglobin a1c in acute ischemic stroke patients with reperfusion therapy. Brain Sci. 2022;12:294.
   Web of Science ®Google Scholar
• Dietrich WD, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke. 1993;24:111–116. doi:10.1161/01.STR.24.1.111
   PubMed Web of Science ®Google Scholar
• Marshall RS. Progress in intravenous thrombolytic therapy for acute stroke. JAMA Neurol. 2015;72:928–934. doi:10.1001/jamaneurol.2015.0835
   PubMed Web of Science ®Google Scholar
• Meigs JB, Nathan DM, Tofler GH, et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham offspring study. JAMA. 2000;283:221–228. doi:10.1001/jama.283.2.221
   PubMed Web of Science ®Google Scholar
• Ding Y, Coulson R, Kamanna VS, Roh DD. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab. 2000;279:E11–17. doi:10.1152/ajpendo.2000.279.1.E11
   PubMed Web of Science ®Google Scholar
• Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the akt site. J Clin Invest. 2001;108:1341–1348. doi:10.1172/JCI11235
   PubMed Web of Science ®Google Scholar
• Pandolfi A, Cilli C, Alberta MM, et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol. 2001;38:71–76. doi:10.1007/s005920170016
   PubMed Web of Science ®Google Scholar
• Ribo M, Molina C, Montaner J, et al. Acute hyperglycemia state is associated with lower tpa-induced recanalization rates in stroke patients. Stroke. 2005;36:1705–1709. doi:10.1161/01.STR.0000173161.05453.90.9f
   PubMed Web of Science ®Google Scholar
• Luitse MJA, Biessels GJ, Rutten GEHM, Kappelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol. 2012;11:261–271. doi:10.1016/S1474-4422(12)70005-4
   PubMed Web of Science ®Google Scholar
• Omi H, Shimizu M, Okouchi M, Ito S, Fukutomi T, Itoh M. Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effect of antidiabetic medicines. J Diabetes Complications. 2002;16:201–208. doi:10.1016/S1056-8727(01)00163-5
   PubMed Web of Science ®Google Scholar
• Slevin M, Garcia-Lara E, Capitanescu B, et al. Monomeric c-reactive protein aggravates secondary degeneration after intracerebral haemorrhagic stroke and may function as a sensor for systemic inflammation. J Clin Med. 2020;10:9. doi:10.3390/jcm10010009
   Web of Science ®Google Scholar
• ElHabr AK, Katz JM, Wang J, et al. Predicting 90-day modified rankin scale score with discharge information in acute ischaemic stroke patients following treatment. BMJ Neurol Open. 2021;3:e000177. doi:10.1136/bmjno-2021-000177
   Google Scholar
• Menon BK, Al-Ajlan FS, Najm M, et al. Association of clinical, imaging, and thrombus characteristics with recanalization of visible intracranial occlusion in patients with acute ischemic stroke. JAMA. 2018;320:1017–1026. doi:10.1001/jama.2018.12498
   PubMed Web of Science ®Google Scholar